ES2190475T3 - Extractos de cartilago de tiburon. - Google Patents

Extractos de cartilago de tiburon.

Info

Publication number
ES2190475T3
ES2190475T3 ES96926300T ES96926300T ES2190475T3 ES 2190475 T3 ES2190475 T3 ES 2190475T3 ES 96926300 T ES96926300 T ES 96926300T ES 96926300 T ES96926300 T ES 96926300T ES 2190475 T3 ES2190475 T3 ES 2190475T3
Authority
ES
Spain
Prior art keywords
cartilago
extracts
extract
liquid
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96926300T
Other languages
English (en)
Inventor
Eric Dupont
Paul Brazeau
Christina Juneau
Daniel H Maes
Kenneth Marenus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cosciens Biopharma Inc
Original Assignee
Les Laboratories Aeterna Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratories Aeterna Inc filed Critical Les Laboratories Aeterna Inc
Application granted granted Critical
Publication of ES2190475T3 publication Critical patent/ES2190475T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicinal Preparation (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCION ESTA RELACIONADA CON EXTRACTOS DE CARTILAGO Y CON UN METODO PARA PRODUCIRLOS. LOS EXTRACTOS DE CARTILAGO DE TIBURON, CON PROPIEDADES ANTIANGIOGENICAS, ANTITUMORALES, ANTIINFLAMATORIAS Y ANTICOLAGENOLITICAS, SE HAN OBTENIDO MEDIANTE UN PROCEDIMIENTO MEJORADO. ESTE PROCEDIMIENTO CONSTA DE UNA FASE DE OBTENCION DE UN HOMOGENATO DE CARTILAGO EN SOLUCION ACUOSA Y DE SEPARACION DE DICHO HOMOGENATO EN UNA FRACCION SOLIDA (EXTRACTO SOLIDO) Y OTRA LIQUIDA QUE SE VUELVE A FRACCIONAR PARA OBTENER UN EXTRACTO LIQUIDO CON MOLECULAS DE PESO MOLECULAR COMPRENDIDO ENTRE 0 Y 500 KDA. LA COMPOSICION DEL EXTRACTO LIQUIDO SE HA INVESTIGADO CON METODOS DIFERENTES. UN NUEVO FRACCIONAMIENTO DE ESTE EXTRACTO DIO LUGAR A LA CARACTERIZACION PRELIMINAR DE ALGUNOS DE SUS COMPONENTES ACTIVOS. DEBIDO A LA MULTIPLICIDAD DE ACTIVIDADES BIOLOGICAS DEL EXTRACTO LIQUIDO TOTAL, ESTE SE PUEDE UTILIZAR PARA TRATAR NUMEROSAS ENFERMEDADES COMO LAS QUE TIENEN COMPONENTES SELECCIONADOS DEL GRUPO CONSISTENTE EN PROLIFERACION TUMORAL, ANGIOGENESIS, INFLAMACION Y COLAGENOLISIS. EL CAMPO DE ACTUACION DE ESTA INVENCION INCLUYE TAMBIEN A VARIAS APLICACIONES COSMETICAS BASADAS EN LA CAPACIDAD DEL EXTRACTO LIQUIDO PARA MEJORAR LA FUNCION DE BARRERA DE LA PIEL. ESTOS EXTRACTOS NO TIENEN EFECTO PERJUDICIAL SOBRE LAS FUNCIONES CORPORALES NORMALES. POR TODO ELLO, ESTOS EXTRACTOS DE CARTILAGO DE TIBURON POSEEN UN VALOR TERAPEUTICO MUY PROMETEDOR. EL PROCEDIMIENTO PARA LA OBTENCION DE EXTRACTOS DE CARTILAGO ES SENCILLO Y EFICIENTE. LOS PRODUCTOS, INESPERADAMENTE VALIOSOS, OBTENIDOS MEDIANTE ESTE METODO SON POR LO TANTO UNA INDICACION DE UN PROCESO NUEVO Y NO EVIDENTE.
ES96926300T 1995-10-30 1996-08-07 Extractos de cartilago de tiburon. Expired - Lifetime ES2190475T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/550,003 US6025334A (en) 1994-04-28 1995-10-30 Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof

Publications (1)

Publication Number Publication Date
ES2190475T3 true ES2190475T3 (es) 2003-08-01

Family

ID=24195326

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96926300T Expired - Lifetime ES2190475T3 (es) 1995-10-30 1996-08-07 Extractos de cartilago de tiburon.

Country Status (27)

Country Link
US (1) US6025334A (es)
EP (1) EP0859622B1 (es)
JP (2) JPH11513990A (es)
KR (1) KR100296016B1 (es)
CN (1) CN1187060C (es)
AT (1) ATE230604T1 (es)
BG (1) BG63907B1 (es)
BR (1) BR9611507A (es)
CA (1) CA2236021C (es)
CO (1) CO4750839A1 (es)
CZ (1) CZ129398A3 (es)
DE (1) DE69625698T2 (es)
DK (1) DK0859622T3 (es)
ES (1) ES2190475T3 (es)
HU (1) HU225490B1 (es)
IL (1) IL119030A (es)
IN (1) IN188198B (es)
IS (1) IS2017B (es)
MX (1) MX9803419A (es)
NO (1) NO981781L (es)
NZ (1) NZ313957A (es)
PL (1) PL187989B1 (es)
RO (1) RO118567B1 (es)
RU (1) RU2181292C2 (es)
TW (1) TW503108B (es)
WO (1) WO1997016197A1 (es)
ZA (1) ZA966726B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380366B1 (en) * 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
GB9621630D0 (en) * 1996-10-17 1996-12-11 Kappa Pharmaceuticals Ltd Treatment of skin disorders
EP0842670A1 (en) * 1996-11-13 1998-05-20 Katsunari Nishihara Biomedical materials
US6379709B1 (en) 1997-02-20 2002-04-30 Industrial Research Limited Angiogenesis inhibitors and activators from shark cartilage
NZ337376A (en) * 1997-03-11 2002-02-01 Aeterna Lab Inc Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
WO1999002548A1 (en) * 1997-07-11 1999-01-21 Cv Technologies Inc. A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
JPH11171782A (ja) * 1997-12-03 1999-06-29 Kaoru Yamane 液体鮫軟骨の製造方法
FR2778558B1 (fr) 1998-05-12 2001-02-16 Oreal Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
US20020009501A1 (en) * 1998-07-23 2002-01-24 Eric Dupont Preparation of cartilage extracts using organic solvents
WO2000010552A2 (en) * 1998-08-24 2000-03-02 Global Vascular Concepts, Inc. Use of anti-angiogenic agents for inhibiting vessel wall injury
KR100355952B1 (ko) * 2000-03-15 2002-10-11 주식회사 코리아나화장품 상어 연골추출물과 비타민 케이 유도체를 함유하는 화장료조성물
EP1267813A2 (de) * 2000-03-31 2003-01-02 Henkel Kommanditgesellschaft auf Aktien Verwendung von protease-inhibitoren in der kosmetik und pharmazie
AU1649802A (en) * 2000-12-20 2002-07-01 Ind Res Ltd Shark meat extract
TWI233361B (en) 2001-04-13 2005-06-01 Gen Hospital Corp Methods of preventing UVB-induced skin damage
AU2002325108A1 (en) * 2001-08-27 2003-03-10 Les Laboratoires Aeterna Inc. Serine protease inhibitor and processes for the preparation thereof
US7504115B2 (en) 2002-02-15 2009-03-17 Ocean Nutrition Canada Limited Shark cartilage extracts and use thereof for immunomodulation
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
CN1761686B (zh) * 2003-03-20 2010-04-28 细川密克朗集团 从软骨鱼类分离的蛋白多糖及其制造方法
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
ES2223291B1 (es) * 2003-08-06 2006-03-16 Bioiberica, S.A. Nuevo uso terapeutico de condroitin sulfato.
US7824711B2 (en) 2003-12-11 2010-11-02 Isto Technologies, Inc. Particulate cartilage system
ES2702607T3 (es) * 2004-01-07 2019-03-04 E L Man Corporation Composición cosmética y método de retardo del crecimiento del vello
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
WO2006059236A2 (en) * 2004-11-16 2006-06-08 Aeterna Zentaris Inc. Method of using cartilage extract for increasing blood parameters
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP4875865B2 (ja) * 2005-08-17 2012-02-15 株式会社日本バリアフリー 変形性関節症の予防及び治療用ＮＴｘ値低減剤
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US7951782B2 (en) 2005-09-29 2011-05-31 Maruha Nichiro Seafoods, Inc Composition effective to prevent or treat adult disease
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
US8435551B2 (en) * 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
AU2008240191B2 (en) * 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
EP2224884A2 (en) * 2007-12-05 2010-09-08 Musculoskeletal Transplant Foundation Cancellous bone implant for cartilage repair
RU2355240C1 (ru) * 2008-01-09 2009-05-20 Федеральное государственное образовательное учреждение высшего профессионального образования "Калининградский государственный технический университет" Способ получения пищевого препарата хондропротекторного действия
EP2262469A4 (en) * 2008-04-15 2013-12-04 Immanence Integrale Dermo Correction Inc SKIN CARE COMPOSITIONS AND METHOD FOR THEIR USE
RU2592850C2 (ru) * 2011-01-19 2016-07-27 Хиросаки Юниверсити Способ крупномасштабного получения протеогликана
US9347081B2 (en) 2011-04-19 2016-05-24 Bioiberica, S.A. Cartilage product
ES2403804B1 (es) * 2011-09-21 2014-07-15 Bioib�Rica, S.A. Producto de cartílago.
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
RU2526825C1 (ru) * 2013-06-18 2014-08-27 Вера Геннадьевна Лихванцева Фармацевтическая антиангиогенная композиция для лечения заболеваний глаз
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN104877009B (zh) * 2015-05-11 2020-08-11 浙江海洋学院 一种赤魟软骨多肽类血管生成抑制因子
KR101901568B1 (ko) 2016-07-04 2018-09-28 주식회사 강스템바이오텍 연골 무세포 파쇄물 및 줄기세포를 포함하는 연골분화 촉진용 복합체 및 그의 용도
KR102154976B1 (ko) * 2018-08-30 2020-09-11 전남대학교산학협력단 구내염 치료용 하이드로겔
KR102369902B1 (ko) * 2021-04-23 2022-03-02 이수한 전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법
KR20220166032A (ko) 2021-06-09 2022-12-16 아스코코리아 주식회사 조립식 캠핑 테이블

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3478146A (en) * 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US4042457A (en) * 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4822607A (en) * 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4350682A (en) * 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
US4356261A (en) * 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
US4486414A (en) * 1983-03-21 1984-12-04 Arizona Board Of Reagents Dolastatins A and B cell growth inhibitory substances
US4656137A (en) * 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5075112A (en) * 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
WO1994012510A1 (en) * 1992-11-30 1994-06-09 Lane I William Processing shark cartilage
RU2019180C1 (ru) * 1993-01-12 1994-09-15 Яков Давидович Безман Средство для лечения подкожной фибросаркомы и способ его получения
EP1155689B1 (en) * 1993-07-19 2006-09-20 Angiotech Pharmaceuticals, Inc. Anti-angiogenic stents and methods of their preparation
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
JPH0870822A (ja) * 1994-09-01 1996-03-19 Makoma Kk カプセル入り食品及びその製造法
PL188137B1 (pl) * 1995-02-03 2004-12-31 Aeterna Lab Inc Zastosowanie wyciągu z chrząstki rekina

Also Published As

Publication number Publication date
IS2017B (is) 2005-06-15
HK1015683A1 (en) 1999-10-22
CA2236021A1 (en) 1997-05-09
JPH11513990A (ja) 1999-11-30
PL187989B1 (pl) 2004-11-30
KR100296016B1 (ko) 2001-10-26
ZA966726B (en) 1997-02-18
DK0859622T3 (da) 2003-05-05
CN1206348A (zh) 1999-01-27
RU2181292C2 (ru) 2002-04-20
BR9611507A (pt) 1999-12-28
US6025334A (en) 2000-02-15
KR19990067245A (ko) 1999-08-16
NO981781D0 (no) 1998-04-21
CN1187060C (zh) 2005-02-02
IS4728A (is) 1998-04-29
NO981781L (no) 1998-06-19
CZ129398A3 (cs) 1998-12-16
JP2003246740A (ja) 2003-09-02
DE69625698D1 (de) 2003-02-13
CA2236021C (en) 2002-07-30
IN188198B (es) 2002-08-31
HUP9802604A2 (hu) 1999-10-28
NZ313957A (en) 2000-05-26
HUP9802604A3 (en) 2001-06-28
EP0859622A1 (en) 1998-08-26
BG102419A (en) 1999-01-29
MX9803419A (es) 1998-10-31
IL119030A (en) 2000-08-13
BG63907B1 (bg) 2003-06-30
RO118567B1 (ro) 2003-07-30
CO4750839A1 (es) 1999-03-31
TW503108B (en) 2002-09-21
PL326888A1 (en) 1998-10-26
DE69625698T2 (de) 2003-10-16
ATE230604T1 (de) 2003-01-15
IL119030A0 (en) 1996-11-14
EP0859622B1 (en) 2003-01-08
HU225490B1 (en) 2006-12-28
WO1997016197A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
ES2190475T3 (es) Extractos de cartilago de tiburon.
ES2188672T3 (es) Extractos de cartilagos de tiburon, procedimiento para la obtencion y utilizaciones de los mismos.
DE60136348D1 (de) Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten
PE799A1 (es) Composicion cosmetica que contiene un antagonista de los receptores del neuropeptido y
ATE476954T1 (de) Zusammensetzungen zur gezielten freisetzung von duftstoffen und aromen
ATE103171T1 (de) Verwendung von algenextrakten zur herstellung von pharmazeutika, kosmetika, nahrungsmitteln oder zum landwirtschaftlichen gebrauch.
DE59705307D1 (de) Kosmetisches reinigungs- und pflegepräparat enthaltend extrakte von pflanzen und algen
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
ES2174039T3 (es) Utilizacion de al menos un peptido que contiene el tripeptido lys-dpro-arg para la preparacion de un medicamento para el tratamiento de la inflamacion.
ES2193364T3 (es) Utilizacion de un extracto de potencilla erecta en el campo cosmetico y farmaceutico.
KR102274597B1 (ko) 분말타입 계면활성제 및 천연분말을 함유하는 온열 인체 세정용 조성물
ES2176495T3 (es) Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida.
ES2035092T3 (es) Producto liquido para el tratamiento estetico de la piel y su procedimiento de fabricacion.
KR101584063B1 (ko) 탈염 용암해수 및 천연 복합 추출물을 함유하는 여드름 개선용 화장료 조성물
RU2180214C1 (ru) Крем-скраб
KR101884297B1 (ko) 허브추출물을 포함한 클렌징 화장료의 혼합 조성물 및 제조방법
KR101893970B1 (ko) 레스베라트롤을 함유하는 화장료 조성물
KR101220903B1 (ko) 피부주름개선용 피부외용제 조성물
CU22866A3 (es) Formulación farmacéutica semisólida que contiene dexcetoprofentrometamol y procedimiento de obtención
ES2690848T3 (es) Utilización cosmética de un extracto de alpechines de olivo para redensificar el cabello
ES2057180T3 (es) Producto para la proteccion, nutricion y tratamiento de la piel.
KR960030917A (ko) 매실 추출물을 함유하는 화장품 조성물
ES2609994B2 (es) Procedimiento para reciclar productos de almazara, preparación así obtenida y usos dados a la misma
NO20022739D0 (no) Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelser
AR010950A1 (es) Metodos de tratamiento de capsulas y formulaciones farmaceuticas secas y pulverizadas.